Related Experiment Video

Updated: May 13, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Breastfeeding and metabolic indicators in Mexican premature newborns

Rebeca Monroy-Torres1, Jaime Naves-Sánchez, Juan Antonio Ortega-García

  • 1Universidad de Guanajuato, Departamento de Medicina y Nutrición, División de Ciencias de la Salud, Campus León. rmonroy79@yahoo.com.mx

Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|March 22, 2013
PubMed

Insights

Premature infants often have poor weight gain and altered metabolic markers. Prolonging breastfeeding and extending follow-up can improve growth and development in these vulnerable infants.

Area of Science:

  • Neonatal nutrition
  • Pediatric metabolic health
  • Infant growth and development

Background:

  • Preterm infants face higher morbidity and mortality due to physiological immaturity.
  • Nutritional interventions are crucial for weight gain, supporting growth, neurological development, and preventing metabolic complications.
  • Breastfeeding duration's impact on preterm infants was analyzed in the first six months of life.

Purpose of the Study:

  • To evaluate the effects of nutritional and metabolic markers in preterm infants.
  • To assess growth indicators and metabolic parameters at the end of the first semester of life.

Main Methods:

  • An analytical, transversal, and comparative study of 100 preterm infants (30-36 weeks gestational age).
  • Measured weight, length, and head circumference at birth and 6-9 months follow-up.
  • Assessed metabolic indicators including glucose, hemoglobin, cholesterol, triglycerides, insulin, urea, creatinine, gamma-glutamyl-transferase, and alkaline phosphatase.

Main Results:

  • Significant differences were observed in hemoglobin, creatinine, and urea levels compared to reference values.
  • Average breastfeeding duration was 4.3 months.
  • Identified risk factors for hypercholesterolemia and noted significant differences in hemoglobin, creatinine, and urea.

Conclusions:

  • Preterm infants exhibited weight gain deficiencies.
  • Biochemical parameters indicate potential metabolic risks.
  • Recommendations include prolonged breastfeeding and extended infant follow-up for monitoring growth and development post-hospitalization.
Abstract

More Related Videos

A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect05:04

A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect

Published on: September 22, 2023

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...